Fibromyalgia in patients infected with HTLV-1 and HTLV-2.

HTLV-1 HTLV-2 fibromyalgia infection pain virus

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2024
Historique:
received: 13 05 2024
accepted: 15 08 2024
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Reports on the association between HTLV-2 infection and the development of diseases in the human host are rare, which has led the scientific community to believe that HTLV-2 is not an important etiological agent of lymphoproliferative or neurodegenerative disorders, which is the case for HTLV-1. In the present study, we demonstrated cases of fibromyalgia in HTLV-1 carriers and, in an unprecedented finding, in two patients with confirmed HTLV-2 infection. A total of 957 individuals visited the Virology Laboratory at the Federal University of Pará for screening and confirmation tests for HTLV-1/2 infection. Individuals with confirmed HTLV-1 and HTLV-2 infection were clinically evaluated for signs and symptoms associated with infection. Sixty-nine individuals (7.2%) were identified as positive for HTLV infection, with 56 confirmed cases of HTLV-1 infection (5.9%), 12 cases of HTLV-2 infection (1.2%) and one case classified as undetermined (0.1%). Sixteen (23.2%) of these patients presented with rheumatological signs and complained of diffuse pain throughout the body; 12 of whom were infected by HTLV-1 (75%) and 4 were infected by HTLV-2 (25%). After anamnesis and careful evaluation, four patients were diagnosed with fibromyalgia, two of whom were infected by HTLV-1 (16.7%; 2/12) and two by HTLV-2 (50%; 2/4). The clinical follow-up and laboratory analysis results are reported in detail in this paper. Considering the clinical cases presented herein as the first reports of patients with HTLV-2 infection with clinical symptoms of fibromyalgia, the importance of further studies on the pathogenicity of HTLV-2, similar to what have already been performed for HTLV-1, is highlighted. Our results also confirm previous evidence of an association between HTLV-1 infection and fibromyalgia.

Sections du résumé

Background UNASSIGNED
Reports on the association between HTLV-2 infection and the development of diseases in the human host are rare, which has led the scientific community to believe that HTLV-2 is not an important etiological agent of lymphoproliferative or neurodegenerative disorders, which is the case for HTLV-1. In the present study, we demonstrated cases of fibromyalgia in HTLV-1 carriers and, in an unprecedented finding, in two patients with confirmed HTLV-2 infection.
Methods UNASSIGNED
A total of 957 individuals visited the Virology Laboratory at the Federal University of Pará for screening and confirmation tests for HTLV-1/2 infection. Individuals with confirmed HTLV-1 and HTLV-2 infection were clinically evaluated for signs and symptoms associated with infection.
Results UNASSIGNED
Sixty-nine individuals (7.2%) were identified as positive for HTLV infection, with 56 confirmed cases of HTLV-1 infection (5.9%), 12 cases of HTLV-2 infection (1.2%) and one case classified as undetermined (0.1%). Sixteen (23.2%) of these patients presented with rheumatological signs and complained of diffuse pain throughout the body; 12 of whom were infected by HTLV-1 (75%) and 4 were infected by HTLV-2 (25%). After anamnesis and careful evaluation, four patients were diagnosed with fibromyalgia, two of whom were infected by HTLV-1 (16.7%; 2/12) and two by HTLV-2 (50%; 2/4). The clinical follow-up and laboratory analysis results are reported in detail in this paper.
Conclusion UNASSIGNED
Considering the clinical cases presented herein as the first reports of patients with HTLV-2 infection with clinical symptoms of fibromyalgia, the importance of further studies on the pathogenicity of HTLV-2, similar to what have already been performed for HTLV-1, is highlighted. Our results also confirm previous evidence of an association between HTLV-1 infection and fibromyalgia.

Identifiants

pubmed: 39247631
doi: 10.3389/fmed.2024.1419801
pmc: PMC11377305
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1419801

Informations de copyright

Copyright © 2024 Inomata Silva, da Cunha Rodrigues, Tsukimata, Botelho, Santos, dos Santos Pereira Neto, Lima, André, Galdino, Monteiro, Yoshikawa, Mendonça, do Amaral, de Britto Pereira Cruz, Onuma, Vallinoto, de Carvalho Klemz and Vallinoto.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.

Auteurs

Bianca Lumi Inomata Silva (BL)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Francisco Erivan da Cunha Rodrigues (FE)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Márcio Yutaka Tsukimata (MY)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Bruno José Sarmento Botelho (BJS)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.

Luciana Cristina Coelho Santos (LCC)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Programa de Pós-graduação em Biologia de Agentes Infecciosos e Parasitário, Universidade Federal do Pará, Belém, Brazil.

Gabriel Dos Santos Pereira Neto (G)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Programa de Pós-graduação em Biologia de Agentes Infecciosos e Parasitário, Universidade Federal do Pará, Belém, Brazil.

Aline Cecy Rocha Lima (ACR)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Programa de Pós-graduação em Biologia de Agentes Infecciosos e Parasitário, Universidade Federal do Pará, Belém, Brazil.

Natália Pinheiro André (NP)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Sarah Marques Galdino (SM)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Danniele Chagas Monteiro (DC)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Gilberto Toshimitsu Yoshikawa (GT)

Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Leonardo Teixeira Mendonça (LT)

Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Juliana Lasmar Ayres do Amaral (JLA)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Rosana de Britto Pereira Cruz (R)

Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Débora Oliveira Onuma (DO)

Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Antonio Carlos Rosário Vallinoto (ACR)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.
Programa de Pós-graduação em Biologia de Agentes Infecciosos e Parasitário, Universidade Federal do Pará, Belém, Brazil.

Bárbara Nascimento de Carvalho Klemz (BN)

Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.

Izaura Maria Vieira Cayres Vallinoto (IMVC)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém, Brazil.
Faculdade de Medicina, Instituto de Ciências Médica, Universidade Federal do Pará, Belém, Brazil.
Programa de Pós-graduação em Biologia de Agentes Infecciosos e Parasitário, Universidade Federal do Pará, Belém, Brazil.

Classifications MeSH